Abstract: The invention relates to new competitive tripeptide inhibitors of trypsin-like serine proteases, their synthesis, pharmaceutical compositions containing the compounds as active ingredients, and the use of the compounds as thrombin inhibitors, anticoagulants and antiinflammatory inhibitors for prophylaxis and treatment of related diseases.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
August 17, 1999
Assignee:
Astra Aktiebolag
Inventors:
Karl Thomas Antonsson, Ruth Elvy Bylund, Nils David Gustafsson, Nils Olov Ingemar Nilsson
Abstract: The invention relates to small cholestyramine pellets that can be prepared by extrusion. The pellets have a high cholestyramine loading and are stable enough to be coated with one or more coating layers. The invention also relates to a process for the preparation of such pellets and to a multiparticulate drug delivery system comprising such pellets.
Type:
Grant
Filed:
March 3, 2017
Date of Patent:
October 15, 2019
Assignee:
Albireo AB
Inventors:
Per-Göran Gillberg, Nils Ove Gustafsson, Nils-Olof Lindberg, Jessica Elversson
Abstract: The invention relates to small cholestyramine pellets that can be prepared by extrusion. The pellets have a high cholestyramine loading and are stable enough to be coated with one or more coating layers. The invention also relates to a process for the preparation of such pellets and to a multiparticulate drug delivery system comprising such pellets.
Type:
Grant
Filed:
May 24, 2018
Date of Patent:
April 7, 2020
Assignee:
Albireo AB
Inventors:
Per-Göran Gillberg, Nils Ove Gustafsson, Nils-Olof Lindberg, Jessica Elversson
Abstract: The invention relates to a pharmaceutical composition comprising an antiviral compound selected from the group consisting of foscarnet, acyclovir, valaciclovir, penciclovir and famciclovir, in admixture with galactolipids and a polar solvent. The pharmaceutical composition can be used in a prophylactic and/or curative treatment of herpesvirus infections in mammals including man, by topical or parenteral administration.
Type:
Grant
Filed:
March 8, 1996
Date of Patent:
September 12, 2000
Assignee:
Astra Aktiebolag
Inventors:
Anders Nils-Erik Carlsson, Bengt Goran Herslof, Stefan Karl Lundquist, Goran Nils Gunnar Nilsson
Abstract: The invention concerns the compounds of the formulas: ##STR1## and protected forms and salts thereof which serve as starting materials in an improved method of synthesizing thrombin and kininogenase inhibitors. The invention further concerns an improved method for synthesizing the inhibitors which utilizes the compounds.
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
March 3, 1998
Assignee:
Astra AB
Inventors:
Karl Thomas Antonsson, Ruth Elvy Bylund, Nils David Gustafsson, Nils Olov Ingemar Nilsson
Abstract: The invention relates to a population of pellets, each pellet comprising cholestyramine and at least about 5% w/w of an acrylate copolymer. The invention also relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets and wherein said pellets are coated with a colon release coating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption.
Type:
Application
Filed:
August 9, 2019
Publication date:
February 13, 2020
Inventors:
Per-Göran Gillberg, Nils Ove Gustafsson, Nils-Olof Lindberg, Jessica Elversson
Abstract: A method for optimizing NILS of exposed lines includes providing a photomask layout which has a first straight line and a second straight line parallel with the first straight line and is applied to a Quasar 90 illumination, and adding a first assist pattern between the first and second straight lines, wherein the first assist pattern has a plurality of geometric patterns with similar size arranging as a line parallel with the first straight line.
Abstract: An immersion pouring spout for introducing molten metal, such as steel, into an ingot mold is provided with a top head and a cylindrical pouring tube including a protective external jacket attached by cement to the pouring tube and extending the entire length of the pouring tube. The jacket material has a thermal conductivity that is less than the thermal conductivity of the pouring tube material.
Type:
Grant
Filed:
October 29, 1984
Date of Patent:
February 3, 1987
Assignee:
Didier-Werke AG
Inventors:
Heinrich Geller, Peter Nold, Heinz Schermer, Ortwin Rave
Abstract: A method for optimizing NILS of exposed lines includes providing a photomask layout which has a first straight line and a second straight line parallel with the first straight line and is applied to a Quasar 90 illumination, and adding a first assist pattern between the first and second straight lines, wherein the first assist pattern has a plurality of geometric patterns with similar size arranging as a line parallel with the first straight line.
Abstract: Imatinib can be used in the treatment of stroke in a new dosage regime, where Imatinib is administered to the patient at a dose of 650 mg/day or higher for at least 3 consecutive days, and preferably administered in a starting dose of 1000 mg/day or higher on day 1, and at a dose in the interval of 650 mg/day to 1000 mg/day on the subsequent days. A method for the treatment of stroke, a pharmaceutical composition and a kit of parts is/are also disclosed.
Type:
Grant
Filed:
February 27, 2017
Date of Patent:
March 23, 2021
Assignees:
Hamra Invest AB, Brain Consultant Nils Gunnar Wahlgren AB
Abstract: The invention relates to new competitive inhibitors of trypsin-like serine proteases, their synthesis, pharmaceutical compositions containing the compounds as active ingredients, and the use of the compounds as thrombin inhibitors, anticoagulants and antiinflammatory inhibitors for prophylaxis and treatment of related diseases, according to the formula wherein A1 represents a structural fragment of formulas A2 represent a structural fragment of formulas B represents a structural fragment of formulas Further described is novel compounds, the new use of compounds and especially new structural fragment in synthesis of pharmaceutical compounds.
Type:
Application
Filed:
March 25, 2005
Publication date:
October 6, 2005
Applicant:
Astrazeneca AB
Inventors:
Karl Antonsson, Ruth Bylund, Nils Gustafsson, Nils Nilsson
Abstract: Pharmaceutical preparation containing an effective amount of acetylsalicylic acid and a compound of Formula I. A1—A2—NH—(CH2)n—B wherein A1, A2, n and B are as defined in the specification, which is either the compound as such, or a stereoisomer thereof, and which may be in the form of a physiologically acceptable salt, in association with a pharmaceutical carrier. The combinations are suitable for use in inhibiting thrombin, or in the treatment or prophylaxis of thrombosis or hypercoagulability in patients in need thereof.
Type:
Grant
Filed:
May 8, 2000
Date of Patent:
January 10, 2006
Assignee:
AstraZeneca AB
Inventors:
Karl Thomas Antonsson, Ruth Elvy Bylund, Nils David Gustafsson, Nils Olov Ingemar Nilsson
Abstract: The invention relates to the use of endogenous metabolites to produce a metabolic profile of a disorder or disease in a subject, e.g. an autoimmune disease, in particular rheumatoid arthritis, and the analysis of such metabolic profiles in order to find disturbances in such profiles in a subject which are caused by or correlated with the said diseases or disorders. Such disturbances can be normalised by treatment of the subject with specified compounds, particularly N-(2-chloro-3,4-dimethoxybenzylideneamino)guanidine or an aminoguanidine.
Type:
Application
Filed:
March 24, 2010
Publication date:
May 3, 2012
Inventors:
Erik Torbjörn Lundstedt, Nils Johan Trygg, Jon Robert Gabrielsson, Gunilla Ekström, Nils Johan Trygg, Jon Robert Gabrielsson, Gunilla Ekström
Abstract: A method for operating a wind turbine configured to supply electrical power to an electrical power supply network via a converter comprises measuring a phase angle and measuring a voltage of the electrical power supply network. A value of at least one parameter for a phase locked loop is determined depending on the measured voltage. The phase locked loop is used to determine a corrected phase angle depending on the measured phase angle and the voltage of the electrical power supply network. The corrected phase angle is input into the converter.
Type:
Application
Filed:
January 18, 2019
Publication date:
July 25, 2019
Applicants:
Nordex Energy GmbH, Woodward Kempen GmbH
Inventors:
Nils-Hendric Schall, Andrzej Geniusz, Nils Hoffmann
Abstract: A filter plate (1) is described on which a filter cloth (4) is disposed across the whole top side and glued or welded to the outer sides, and which is used for filtering off particles from a liquid. The plate has a large number of apertures (2), each individual aperture area being at most 2.25 cm.sup.2. The total free open area of the plate is 70-90% of the total plate area and the thickness of the plate is at least 5 mm.
Abstract: A process and apparatus for the preparation of improved cellulose pulps is provided, in which defibered pulp is screened for removal of shives, and fibers with low bonding ability are removed in hydrocyclones, and rejects from the hydrocyclones are treated in refiner. In the process a specific combination of characteristics for the hydrocyclones and the volumetric flow is used in order to prepare pulps which give products of improved qualities, such as higher tensile strength, tear strength, light-scattering, surface smoothness, and especially low shive content.
Abstract: A method for operating a wind turbine configured to supply electrical power to an electrical power supply network via a converter comprises measuring a phase angle and measuring a voltage of the electrical power supply network. A value of at least one parameter for a phase locked loop is determined depending on the measured voltage. The phase locked loop is used to determine a corrected phase angle depending on the measured phase angle and the voltage of the electrical power supply network. The corrected phase angle is input into the converter.
Type:
Grant
Filed:
January 18, 2019
Date of Patent:
July 28, 2020
Assignees:
Nordex Energy GmbH, Woodward Kempen GmbH
Inventors:
Nils-Hendric Schall, Andreas Genius, Nils Hoffmann
Abstract: Upon the occurrence of the nil pick, an amount of product that is available in the warehouse is determined as is a demand of the product from the replenishment settings. When the amount of product is sufficient to partially satisfy the demand, first instructions are transmitted to the warehouse instructing the warehouse to send selected amounts of the product to selected retail stores. When the amount of product is insufficient to satisfy any of the demand, a message is sent to a secondary supplier instructing the secondary supplier to ship products to the warehouse. Instructions are transmitted to the warehouse to perform a verification of an accuracy of the replenishment settings.
Type:
Application
Filed:
July 10, 2018
Publication date:
January 31, 2019
Inventors:
Greg A. Bryan, Cristy C. Brooks, David B. Brightwell, Matthew A. Jones, Benjamin D. Enssle, Jesse L. Eaton, Todd D. Mattingly
Abstract: The invention relates to compounds of the formulaA.sup.1 --A.sup.2 --NH--(CH.sub.2).sub.n --B Formula IandA.sup.1 --A.sup.2 --NH--(CH.sub.2).sub.n --B--D Formula Vas well as stereoisomers and physiologically acceptable salts thereof which act as competitive inhibitors of trypsin-like serine proteases, particularly kininogenases. The invention further relates to pharmaceutical compositions containing the compounds as active ingredients and the use of the compounds as kininogenase inhibitors and in the treatment of diseases related to kinin formation.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
January 5, 1999
Assignee:
Astra Aktiebolag
Inventors:
Karl Thomas Antonsson, Ruth Elvy Bylund, Nils David Gustafsson, Nils Olov Ingemar Nilsson
Abstract: Disclosed herein is a light module and a method for operating the light module. The light module includes a light source; an electronic circuit for driving the light source; where the electronic circuit includes a current source, where the current source is designated for generating and controlling a control current for driving the light source, and a protection controller, where the protection controller is designated for interrupting the control current to the light source in an event in which the current source fails. The light module and the related method address an eye-safe operation of the light module, specifically for a laser light source included by the light module to achieve compliance to laser safety class 1.
Type:
Application
Filed:
July 24, 2020
Publication date:
September 8, 2022
Inventors:
Benjamin Rein, Nils Berner, Philipp Nils Raith